Cargando…

An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker

BACKGROUND: Pancreatic cancer is associated with an extremely poor prognosis, so new biomarkers that can detect the initial stages are urgently needed. The significance of serum microRNA (miR) levels in pancreatic neoplasm such as pancreatic cancer and intraductal papillary mucinous neoplasm (IPMN)...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Takuma, Fujiya, Mikihiro, Konishi, Hiroaki, Sasajima, Junpei, Fujibayashi, Shugo, Hayashi, Akihiro, Utsumi, Tatsuya, Sato, Hiroki, Iwama, Takuya, Ijiri, Masami, Sakatani, Aki, Tanaka, Kazuyuki, Nomura, Yoshiki, Ueno, Nobuhiro, Kashima, Shin, Moriichi, Kentaro, Mizukami, Yusuke, Kohgo, Yutaka, Okumura, Toshikatsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793347/
https://www.ncbi.nlm.nih.gov/pubmed/29385987
http://dx.doi.org/10.1186/s12885-018-4006-5
_version_ 1783296931366174720
author Goto, Takuma
Fujiya, Mikihiro
Konishi, Hiroaki
Sasajima, Junpei
Fujibayashi, Shugo
Hayashi, Akihiro
Utsumi, Tatsuya
Sato, Hiroki
Iwama, Takuya
Ijiri, Masami
Sakatani, Aki
Tanaka, Kazuyuki
Nomura, Yoshiki
Ueno, Nobuhiro
Kashima, Shin
Moriichi, Kentaro
Mizukami, Yusuke
Kohgo, Yutaka
Okumura, Toshikatsu
author_facet Goto, Takuma
Fujiya, Mikihiro
Konishi, Hiroaki
Sasajima, Junpei
Fujibayashi, Shugo
Hayashi, Akihiro
Utsumi, Tatsuya
Sato, Hiroki
Iwama, Takuya
Ijiri, Masami
Sakatani, Aki
Tanaka, Kazuyuki
Nomura, Yoshiki
Ueno, Nobuhiro
Kashima, Shin
Moriichi, Kentaro
Mizukami, Yusuke
Kohgo, Yutaka
Okumura, Toshikatsu
author_sort Goto, Takuma
collection PubMed
description BACKGROUND: Pancreatic cancer is associated with an extremely poor prognosis, so new biomarkers that can detect the initial stages are urgently needed. The significance of serum microRNA (miR) levels in pancreatic neoplasm such as pancreatic cancer and intraductal papillary mucinous neoplasm (IPMN) diagnosis remains unclear. We herein evaluated the usefulness of miRs enclosed in serum exosomes (ExmiRs) as diagnostic markers. METHODS: The ExmiRs from patients with pancreatic cancer (n = 32) or IPMN (n = 29), and patients without neoplasms (controls; n = 22) were enriched using ExoQuick-TC™. The expression of ExmiRs was evaluated using a next-generation sequencing analysis, and the selected three miRs through this analysis were confirmed by a quantitative real-time polymerase chain reaction. RESULTS: The expression of ExmiR-191, ExmiR-21 and ExmiR-451a was significantly up-regulated in patients with pancreatic cancer and IPMN compared to the controls (p < 0.05). A receiver operating characteristic curve analysis showed that the area under the curve and the diagnostic accuracy of ExmiRs were 5–20% superior to those of three serum bulky circulating miRs (e.g.; ExmiR-21: AUC 0.826, accuracy 80.8%. Circulating miR-21: AUC 0.653, accuracy 62.3%). In addition, high ExmiR-451a was associated with mural nodules in IPMN (p = 0.010), and high ExmiR-21 was identified as a candidate prognostic factor for the overall survival (p = 0.011, HR 4.071, median OS of high-ExmiR-21: 344 days, median OS of low-ExmiR-21: 846 days) and chemo-resistant markers (p = 0.022). CONCLUSIONS: The level of three ExmiRs can thus serve as early diagnostic and progression markers of pancreatic cancer and IPMN, and considered more useful markers than the circulating miRs (limited to these three miRs). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4006-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5793347
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57933472018-02-12 An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker Goto, Takuma Fujiya, Mikihiro Konishi, Hiroaki Sasajima, Junpei Fujibayashi, Shugo Hayashi, Akihiro Utsumi, Tatsuya Sato, Hiroki Iwama, Takuya Ijiri, Masami Sakatani, Aki Tanaka, Kazuyuki Nomura, Yoshiki Ueno, Nobuhiro Kashima, Shin Moriichi, Kentaro Mizukami, Yusuke Kohgo, Yutaka Okumura, Toshikatsu BMC Cancer Research Article BACKGROUND: Pancreatic cancer is associated with an extremely poor prognosis, so new biomarkers that can detect the initial stages are urgently needed. The significance of serum microRNA (miR) levels in pancreatic neoplasm such as pancreatic cancer and intraductal papillary mucinous neoplasm (IPMN) diagnosis remains unclear. We herein evaluated the usefulness of miRs enclosed in serum exosomes (ExmiRs) as diagnostic markers. METHODS: The ExmiRs from patients with pancreatic cancer (n = 32) or IPMN (n = 29), and patients without neoplasms (controls; n = 22) were enriched using ExoQuick-TC™. The expression of ExmiRs was evaluated using a next-generation sequencing analysis, and the selected three miRs through this analysis were confirmed by a quantitative real-time polymerase chain reaction. RESULTS: The expression of ExmiR-191, ExmiR-21 and ExmiR-451a was significantly up-regulated in patients with pancreatic cancer and IPMN compared to the controls (p < 0.05). A receiver operating characteristic curve analysis showed that the area under the curve and the diagnostic accuracy of ExmiRs were 5–20% superior to those of three serum bulky circulating miRs (e.g.; ExmiR-21: AUC 0.826, accuracy 80.8%. Circulating miR-21: AUC 0.653, accuracy 62.3%). In addition, high ExmiR-451a was associated with mural nodules in IPMN (p = 0.010), and high ExmiR-21 was identified as a candidate prognostic factor for the overall survival (p = 0.011, HR 4.071, median OS of high-ExmiR-21: 344 days, median OS of low-ExmiR-21: 846 days) and chemo-resistant markers (p = 0.022). CONCLUSIONS: The level of three ExmiRs can thus serve as early diagnostic and progression markers of pancreatic cancer and IPMN, and considered more useful markers than the circulating miRs (limited to these three miRs). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4006-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-31 /pmc/articles/PMC5793347/ /pubmed/29385987 http://dx.doi.org/10.1186/s12885-018-4006-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Goto, Takuma
Fujiya, Mikihiro
Konishi, Hiroaki
Sasajima, Junpei
Fujibayashi, Shugo
Hayashi, Akihiro
Utsumi, Tatsuya
Sato, Hiroki
Iwama, Takuya
Ijiri, Masami
Sakatani, Aki
Tanaka, Kazuyuki
Nomura, Yoshiki
Ueno, Nobuhiro
Kashima, Shin
Moriichi, Kentaro
Mizukami, Yusuke
Kohgo, Yutaka
Okumura, Toshikatsu
An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
title An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
title_full An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
title_fullStr An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
title_full_unstemmed An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
title_short An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
title_sort elevated expression of serum exosomal microrna-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793347/
https://www.ncbi.nlm.nih.gov/pubmed/29385987
http://dx.doi.org/10.1186/s12885-018-4006-5
work_keys_str_mv AT gototakuma anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT fujiyamikihiro anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT konishihiroaki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT sasajimajunpei anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT fujibayashishugo anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT hayashiakihiro anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT utsumitatsuya anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT satohiroki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT iwamatakuya anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT ijirimasami anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT sakataniaki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT tanakakazuyuki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT nomurayoshiki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT uenonobuhiro anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT kashimashin anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT moriichikentaro anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT mizukamiyusuke anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT kohgoyutaka anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT okumuratoshikatsu anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT gototakuma elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT fujiyamikihiro elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT konishihiroaki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT sasajimajunpei elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT fujibayashishugo elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT hayashiakihiro elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT utsumitatsuya elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT satohiroki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT iwamatakuya elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT ijirimasami elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT sakataniaki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT tanakakazuyuki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT nomurayoshiki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT uenonobuhiro elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT kashimashin elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT moriichikentaro elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT mizukamiyusuke elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT kohgoyutaka elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker
AT okumuratoshikatsu elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker